Bioventix Share Discussion Threads

[maddox] 28/3/2023 17:09

Excellent results - great to see the post-Covid recovery with Troponin's strong growth continuing. The quality metrics of BVXP are exceptional - so always tends to command a high p/e. BVXP's track record of paying additional special dividends is a further attraction but the 20% hike in the interim dividend shows confidence. finnCap are forecasting 9% growth for this year and next - which will be very welcome if it comes through against the worrying economic backdrop.

Whilst, still very early days, their Alzheimer's test is a very exciting prospect. It's still in the development phase, a good few years away from being commercialised and there are competitors on the same pathway - so no guaranteed success. The search for an early stage blood test for Alzheimer's is the holy grail of diagnostic testing - a potential blockbuster - so to have a horse in this race is wonderful.

[piedro] 28/3/2023 15:10

FWIW ...



Note:
I use H-1 and H-2 to represent the calendar year {Jan-Jun and Jul-Dec}
as company years can be confusing

[doctor888] 28/3/2023 14:31

Since H1 in 2012, H2 revenues have always exceeded H1 of that year, and H2 of the prior year. Let's hope this continues.

[stepone68] 28/3/2023 14:17

I struggle a bit to find forecasts these days. I used to use Yahoo Finance then sharecast for a while. There were other options, but they all seem to fall by the wayside. I got some on a website called MarketScreener. Last September they were forecasting sales of 10.4 for the year ended June 22, which turned out to be 11.8m, which is quite an underestimate. At the moment they are showing 12.8 for the current year. If that turns out to be correct then the current six months would have been £6.9m, which is LESS than the same six month last year (£7.0m).

Was the 7.0m (from Jan to June last year) a fluke? It was 48% higher than the previous six months (ending Dec 2021). And it means that the 6 months just reported, was actually 15% DOWN on the previous 6.

I'd not really seen BVXP sales do this before - I mean, it's not a seasonal business, so you would think sales growth would be pretty smooth through the year.

Thinking about it, my own suggestion of 14.5m for the year would need £8.6m in H2, i.e. a near 50% rise from H1. Maybe I am being too optimistic after all.

[igbertsponk] 28/3/2023 14:15

Quite a lot of trades today, hope we're not on the radar!

[igbertsponk] 28/3/2023 11:25

"we are pleased to see a solid performance of our core business and look forward to this continuing over the remainder of the year"
That's pretty bullish for the traditionally VERY conservative BVXP.
On the Alzheimers test "the outlook remains exciting" is also pretty bullish.
I'm happy to remain invested and may well add on any dips. This company has never let us investors down. They signal when things won't be super and usually outperform. And the Board are bargain prices. I was pleased to see them take some reward off the table recently selling some shares.

[stepone68] 28/3/2023 10:52

Is that Turnover growth likely to continue for rest of the year? Growth had been a lot lower over the last 5 years - more like 10-15%. Is this down to Troponin?

If we get the same growth to the end of the year that would be turnover around 14.5m, Operating profit almost 10m, and EPS roughly 180p, for a P/E of 22. (Lots of assumptions in that figure, but my forecasts have always turned out to be low in previous years except for 2021).

However, the share price is largely unchanged over the last 4 years. Don't know what it would take to change that, the company is just too small for many.

What do people think is going to happen in the medium/long term here. Will the company get sold at some point? When will Peter Harrison retire? I know nobody knows the answers, but happy for some idle speculation in the meantime :-)

[janeann] 27/3/2023 10:17

also added a few... nice increase in dividend and very positive results. whats not to like?

[melody9999] 27/3/2023 09:59

Yep - continuing to build a position - added a few more this am.

I used to go fishing - and when the river was high, I fished in different places out of the main stream.... those pools used to hold some good fish. And I use the analogy because BVXP is out of the mainstream and unaffected by current macro events. A good place to be fishing IMV but DYOR!

[igbertsponk] 27/3/2023 08:46

Indeed, such a super well-run company. Congrats if they're reading.

[suetballs] 27/3/2023 07:39

Nice half year results and a 20% dividend hike.
Looks like some excitement in Gothenberg too.
Happy to hold.
Suet

[stepone68] 27/2/2023 09:36

Thanks for the additional info, I realise there are still market makers involved with some stocks, but I still think these should be thought of as trades, and that the buy/sell labels assigned by websites should be ignored as meaningless.

[alter ego] 26/2/2023 08:08

and the market maker will have received stock from someone who sold in a separate transaction of which we know nothing. In my experience the quoted spread is often misleadingly wide and purchases are often done well within the implied mid price.

[melton john] 25/2/2023 19:09

Except that with SETSqx stocks the counterparty isn't a someone its a market maker. For whatever reason the trade price was below the mid point of bid and ask and the market makers give the impression that melody9999's trade was a sell from him to the market maker when he knows he bought some. Hope that helps.

[stepone68] 25/2/2023 14:08

There's only one transaction - it's a trade, with both a buyer and a seller.

[alter ego] 24/2/2023 13:09

then that would have appeared as a different transaction - can you identify the price of that sale?

[stepone68] 24/2/2023 12:43

It was a sell - someone sold them to you !!

[melody9999] 24/2/2023 11:41

Just added a few more at 3884p Shown as a sell.

[igbertsponk] 02/2/2023 09:40

I said he'd sold £2m!!!
I'm not going to criticise the CEO though, the best run company on AiM by a country mile and he thoroughly deserves his £££.

[sharw] 01/2/2023 17:49

I suspect the drop is not on the options but on the CEO selling about 14% of his holding raising over £2m. Not only that, but doing so immediatelely before the close period is a red flag in some books.

[igbertsponk] 01/2/2023 16:50

Bit of a drop as Directors (mostly CEO) exercise options and cash in £2m of shares at £37.50

[strollingmolby] 30/1/2023 10:11

Thanks Maynard - added to the header.

SM

[suetballs] 29/1/2023 19:06

An interesting listen - thanks for posting TMFMayn.
Looks like £40 is a reasonable current value.
Suet

[tmfmayn] 29/1/2023 17:47

[Podcast] BIOVENTIX With Roland Head And Maynard Paton #BVXP


A podcast about antibody specialist BIOVENTIX with shareholders Roland Head and Maynard Paton. We talked about the wonderful longevity of diagnostic antibodies, the group's super financials, the potential for Alzheimer's testing and management's remarks at the AGM:



Show notes here: